Breakfast and Industry Symposia

Additional details to come.

IO Essentials: Solid Tumor Interventions

Moderators: Christos Georgiades, MD, PhD, Johns Hopkins University; Nishita Kothary, MD, FSIR, Stanford School of Medicine

• Physics of Ablation Modalities, Christos Georgiades, MD, PhD, Johns Hopkins University
• Liver: Introduction to Ablation and Guidelines Overview, Nishita Kothary, MD, FSIR, Stanford School of Medicine
• Lung: Introduction to Ablation and Guidelines Overview, Stephen Hunt, MTR, MD, PhD, FSIR, University of Pennsylvania
• RCC: Introduction to Ablation and Guidelines Overview, Erica Alexander, MD, Memorial Sloan Kettering Cancer Center
• Radioembolization: Getting Started in Y90, Juan Gimenez, MD, Ochsner Health
• Intro to TACE and Patient Management, Zach Berman, MD, UC San Diego
• Pain Management Techniques and IO, *Rahul Sheth, MD, MD Anderson Cancer Center

Intra- and Extrahepatic Biliary

Moderators: William Rilling, MD, FSIR, Medical College of Wisconsin; Muneeb Ahmed, MD, FSIR, Beth Israel Deaconess Medical Center/Harvard Medical School

• Actionable Mutations and Systemic Therapy Update, Richard S. Finn, MD, Geffen School of Medicine at UCLA
• Surgical Considerations for Intrahepatic Cholangiocarcinoma, Talia Baker, MD, University of Utah Health
• Combination Therapy for Intrahepatic Disease, William Rilling, MD, FSIR, Medical College of Wisconsin
• Endobiliary Therapies for Extrahepatic Disease, Kaiwen Huang, MD, MS, PhD, National Taiwan University
• Post-Surgical Biliary Disasters: M&M, Prof. Adam Hatzidakis, MD, AHEPA University Hospital of Thessalinoki/Aristotle Medical School

Scientific Oral Abstracts

Additional details to come.

Expo Hall, Lunch and Industry Symposia

Additional details to come.

Renal/GU

Moderators: David Breen, MD, MRCP, FRCR, University Hospitals Southampton; Rodrigo Gobbo, MD, PhD, Hospital Israelita Albert Einstein

• T1A and Current Guidelines, Rodrigo Gobbo, MD, PhD, Hospital Israelita Albert Einstein
• Surgical Perspectives on Percutaneous Ablation, *Inderbir S. Gill, MD, University of Southern California
• Ablation in Patients with Chronic Renal Disease, Christos Georgiades, MD, PhD, Johns Hopkins University
• Central Renal Cancer and Ablation in Difficult Locations, Grant Schmit, MD, Mayo Clinic
• T1B Disease: What is the Current Role of IR? AJ Gunn, MD, University of Alabama at Birmingham

Sarcoma/Desmoids

Moderators: Afshin Gangi, MD, PhD, University Hospital of Strasbourg/NHC; Jack Jennings, MD, PhD, Washington University St. Louis

• Pivotal Trials and NCCN Guideline Updates, Sean M. Tutton, MD, FSIR, FCIRSE, UCSD Health
• MDT Care for Desmoids, Bernd Kasper, MD, PhD, University of Heidelberg/Mannheim University Medical Center
• Cryoablation for Desmoid Tumors, Afshin Gangi, MD, PhD, University Hospital of Strasbourg/NHC
• Treatment of Primary and Metastatic Sarcoma, Jack Jennings, MD, PhD, Washington University St. Louis

Y90 Dosimetry Hands-on: Beginners

Additional details to come.

mCRC

Moderators: Martijn Meijerink, MD, PhD, Amsterdam UMC; Yuman Fong, MD, PhD, City of Hope Medical Center

• Current Landscape of Colorectal Disease, TBD
• Overview of Surgical Strategies and Trends in Management of Colorectal Mets, Yuman Fong, MD, PhD, City of Hope Medical Center
• Synergy with Systemic and Locoregional Therapies: Expanding the Curative Role, Martijn Meijerink, MD, PhD, Amsterdam UMC
• Embolic Treatment and Radiation Segmentectomy, Guy Johnson, MD, PharmD, University of Washington
• Optimizing the Liver for Surgical Resection, José Hugo Mendes Luz, MD, INCA National Cancer Institute of Brazil

Must-Know Studies for MDT Tumor Board

Moderators: Phillipe Pereira, MD, SLK Kliniken GmbH Heilbronn; Rony Avritscher, MD, University of Texas MD Anderson Cancer Center; *Terence P. Gade, MD, PhD, University of Pennsylvania

• The Importance of Trials and Registries in Interventional Oncology, Phillipe Pereira, MD, SLK Kliniken GmbH Heilbronn
• ACCLAIM, Constantinos T. Sofocleous, MD, PhD, FSIR, FCIRSE, Memorial Sloan Kettering Cancer Center
• IMbrave150, *Ahmed Kaseb, MD, MD Anderson Cancer Center
• LAUNCH, Lynn Jeanette Savic, MD, Universitätsmedizin Charité Berlin
• Dosisphere, S. Cheenu Kappadath, PhD, FAAPM, University of Texas MD Anderson Cancer Center

Y90 Resin

Moderators: Ammar Sarwar, MD, FSIR, Beth Israel Deaconess Medical Center; Irene Bergellini, MD, Candiolo Cancer Institute

• Updates in Dosimetry with Resin Microspheres Using Pre-Calibration Vials, Marnix Lam, MD, PhD, University Medical Center Utrecht
• Radiation Segmentectomy with Resin Microspheres, *Nima Kokabi, MD, UNC Chapel Hill
• Updates from the RESIN Registry, *Daniel Brown, MD, Vanderbilt University
• Resin Radioembolization for Cholangiocarcinoma, Irene Bergellini, MD, Candiolo Cancer Institute
• Challenging Clinical Scenarios in Advanced Resin Radioembolization, Ammar Sarwar, MD, FSIR, Beth Israel Deaconess Medical Center

Expo Hall and Discovery Theatre

Additional details to come.

mCRC Tumor Board

Moderators: Constantinos T. Sofocleous, MD, PhD, FSIR, FCIRSE, Memorial Sloan Kettering Cancer Center; Martijn Meijerink, MD, PhD, Amsterdam UMC

Faculty: Guy Johnson, MD, PharmD, University of Washington; Yuman Fong, MD, PhD, City of Hope Medical Center; Heather McGee, MD, PhD, City of Hope Medical Group

Trivia Night

Additional details to come.

Breakfast and Industry Symposia

Additional details to come.

IO Essentials: Preparing for Tumor Boards

Moderators: Stephen Hunt, MTR, MD, PhD, FSIR, University of Pennsylvania; *Nadine Abi-Jaoudeh, MD, UC Irvine

• BCLC Immunotherapy: Current Status and Outcomes, Cristal Brown, MD, MHS, UT Austin Dell Medical School
• Liver Transplantation: Patient Selection, Anatomy, and Outcomes, Jennifer Berumen, MD, UC San Diego
• Tumor Board, All above faculty; Dimitrios Filippiadis, MD, PhD, MSc, EBIR, University General Hospital Attikon; Nishita Kothary, MD, FSIR, Stanford School of Medicine

Early and Intermediate Stage HCC

Moderators: Edward Kim, MD, FSIR, Mount Sinai Health Systems; Sarah White, MD, MS, Medical College of Wisconsin

• Curative Options in Early Stage HCC, Roberto Iezzi, MD, Fondazione Pol Gemelli IRCCS Catholic University
• Combining Locoregional and Systemic Thearpy: What, When, and Where, Ronald S. Arellano, MD, Massachusetts General Hospital
• Downstaging Strategies, Franco Orsi, MD, EBIR, FCIRSE, European Institute of Oncology (IRCCS)
• TACE vs. Y90 in Intermediate HCC, Sarah White, MD, MS, Medical College of Wisconsin
• Sequencing Multiple Therapies, *Carrie Frenette, MD, Scripps

Scientific Oral Abstracts

Additional details to come.

Expo Hall, Lunch and Industry Symposia

Additional details to come.

Prostate/GU

Moderators: David Woodrum, MD, PhD, Mayo Clinic; Erica Knavel Koepsel, MD, University of Wisconsin Madison

• Current Status of Prostate Cancer and Patient Selection for Focal Therapy, *Amir Lebastch, MD, University of Southern California
• Intro to Critical Anatomy in Prostate Ablation, David Woodrum, MD, PhD, Mayo Clinic
• Energy Modalities for Focal Prostate Cancer Treatment, Eric M. Walser, MD, FACR, The University of Texas Medical Branch
• MRI-Guided Prostate Interventions, Erica Knavel Koepsel, MD, University of Wisconsin Madison
• Prostate Cancer Recurrence and CT-Guided Prostate Interventions, Vijay Ramalingam, MD, FSIR, Beth Israel Deaconess Medical Center/Harvard Medical School

Y90 Dosimetry Hands-on: Advanced

Additional details to come.

MSK Basic to Advanced

Moderators: Afshin Gangi, MD, PhD, University Hospital of Strasbourg/NHC; Jack Jennings, MD, PhD, Washington University St. Louis

• Imaging and Biopsy of Bone and Soft Tissue Lesions, Anthony Tadros, MD, UC San Diego
• Cement and Screws, Steven Yevich, MD, MPH, MD Anderson Cancer Center
• Cement Augmentation and Osteosynthesis in the Treatment of Painful Bone Metastases, Brandon M. Key, MD, Medical College of Wisconsin
• Basics of Spine Ablation and Role of Combination Therapy, *Anderanik Tomasian, MD, University of Southern California
• Ablation and Combined Radiation and Ablation Therapy for Extra-Spinal Lesions, Anil Nicholas Kurup, MD, Mayo Clinic
• Neuromonitoring and Thermoprotective Techniques, Resten Imaoka, MD, Washington University
• Complications of MSK Ablation, Alexis Kelekis, MD, PhD, EBIR, National and Kapodistrian University of Athens

Interventional Oncology and Immunotherapy

Moderators: Prof. S. Nahum Goldberg, MD, FSIR, FCIRSE, Hadassah Hebrew University Medical Center; *Terence P. Gade, MD, PhD, University of Pennsylvania

• General Overview: Where Are We Currently? Gosse J. Adema, PhD, Radboud University Medical Center
• Immunotherapy and Percutaneous Ablation: What's New and Where Are We Going? Michal Mauda-Havakuk, MD, PhD, Tel-Aviv Sourasky Medical Center
• Immunotherapy and Intra-Arterial Therapy: What's New and Where Are We Going? Rony Avritscher, MD, University of Texas MD Anderson Cancer Center
• Positive Effects of Local Therapies, Prof. S. Nahum Goldberg, MD, FSIR, FCIRSE, Hadassah Hebrew University Medical Center

Head and Neck Cancers

Moderators: Uei Pua, MBBS, FRCR, Mmed, FAMS, FSIR, FCIRSE, FAAC, Tan Tock Seng Hospital; Kazim H. Narsinh, MD, UCSF

• Interventions for Head and Neck Cancers, Uei Pua, MBBS, FRCR, Mmed, FAMS, FSIR, FCIRSE, FAAC, Tan Tock Seng Hospital
• Intra-Arterial Therapies for Head and Neck Tumors, Stephen Chen, MD, UT MD Anderson Cancer Center
• Ablation for Primary and Metastatic Thyroid Cancer, Giovanni Mauri, MD, Europena Institute of Oncology
• Emergency Intervention in Head and Neck Cancers, Stephen W. Hetts, UCSF

Palliative Interventions

Moderators: Dimitrios Filippiadis, MD, PhD, MSc, EBIR, University General Hospital Attikon; Marwan Moussa, MD, Beth Israel Deaconess Medical Center/Harvard Medical School

• Image-Guided Injections, Dimitrios Filippiadis, MD, PhD, MSc, EBIR, University General Hospital Attikon
• Nerve Cryoablation: Approaches and Techniques, Marwan Moussa, MD, Beth Israel Deaconess Medical Center/Harvard Medical School
• Palliative Venous Interventions, Dong Il Gwon, MD, PhD, University of Ulsan College of Medicine/Asan Medical Center
• Pancreatic IRE: Palliative or Ready for Prime Time? Raj Narayanan, MD, Miami Cancer Institute/Baptist Health SF

Expo Hall and Discovery Theatre

Additional details to come.

Oligomets Tumor Board

Moderators: David Breen, MD, MRCP, FRCR, University Hospitals Southampton; *Matthew Callstrom, MD, PhD, Mayo Clinic

Faculty: Alexis Kelekis, MD, PhD, EBIR, National and Kapodistrian University of Athens; *Alexandra Drakaki, MD, UCLA; Jess Maxwell, MD, MBA, MD Anderson Cancer Center; Ann Radlow, MD, MPH, UCLA Dept. of Radiation Oncology

Sunday Soiree*

BO beau kitchen + rooftap, first floor

* Sunday Soiree attendance requires an additional fee.